XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Description of Business and Significant Accounting Policies - Additional Information (Detail)
€ in Millions, $ in Millions
1 Months Ended 9 Months Ended
Jun. 27, 2024
Dec. 31, 2023
USD ($)
Jan. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Sep. 30, 2024
USD ($)
Segment
Sep. 30, 2024
EUR (€)
Jun. 30, 2024
USD ($)
Jul. 01, 2013
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of future royalties         1.00%      
Number of operating segment | Segment         1      
Loss on purchase commitments | €           € 56.6    
Sagard                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of royalty on net sales         1.00%      
Percentage of royalty on future net sales   1.00%            
Insulin                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Loss on purchase commitments   $ 64.8     $ 62.6      
Tyvaso DPI                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of royalty on net sales         10.00%      
Percentage of royalty on future net sales         9.00%      
Percentage of royalty on net revenue         10.00%      
Percentage of future royalties         9.00%      
Maximum | AFREZZA product sales                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Sales return right following product expiration in months         12 months      
Minimum | AFREZZA product sales                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Sales return right following product expiration in months         6 months      
Convertible Promissory Note | Thirona Bio, Inc.                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Increased interest rate 10.00%              
Principal amount         $ 8.0   $ 8.0  
Purchase of available-for-sale securities     $ 5.0 $ 3.0        
Interest rate       6.00%        
MidCap Credit Facility                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Principal amount   $ 33.3            
Milestone Rights Liability | Deerfield                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Contingent liability remain payable               $ 50.0
Milestone Rights Liability | Maximum | Deerfield                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Contingent liability for milestone payments               $ 90.0